Your browser doesn't support javascript.
loading
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources.
Schmidts, Andrea; Marsh, Leah C; Srivastava, Ambike A; Bouffard, Amanda A; Boroughs, Angela C; Scarfò, Irene; Larson, Rebecca C; Bedoya, Felipe; Choi, Bryan D; Frigault, Matthew J; Bailey, Stefanie R; Leick, Mark B; Vatsa, Sonika; Kann, Michael C; Prew, Michelle S; Kleinstiver, Benjamin P; Joung, J Keith; Maus, Marcela V.
Affiliation
  • Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Marsh LC; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Srivastava AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Boroughs AC; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bedoya F; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Choi BD; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bailey SR; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Vatsa S; Cellular Immunotherapy Program and Department of Neurosurgery, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Prew MS; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Kleinstiver BP; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Joung JK; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Immunother Cancer ; 8(2)2020 09.
Article in En | MEDLINE | ID: mdl-32900862
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transduction, Genetic / Immunotherapy, Adoptive / Lentivirus / Antigen-Presenting Cells Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Immunother Cancer Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transduction, Genetic / Immunotherapy, Adoptive / Lentivirus / Antigen-Presenting Cells Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Immunother Cancer Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido